Effects of Celecoxib After Percutaneous Coronary Intervention
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Several studies including ours have reported that celecoxib improves endothelium-dependent
vasodilation and reduces inflammation and neointimal hyperplasia. Our hypothesis is that
celecoxib may reduce the late luminal loss after coronary stent implantation
(paclitaxel-eluting stent.